| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |